• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

LabStat expenses prompt ADAC to shut down project

Article

LabStat expenses prompt ADAC to shut down projectThe high cost of completing development on its LabStat laboratory information system has caused ADAC Laboratories to shut down the project, the Milpitas, CA, vendor announced last month. ADAC will

LabStat expenses prompt ADAC to shut down project

The high cost of completing development on its LabStat laboratory information system has caused ADAC Laboratories to shut down the project, the Milpitas, CA, vendor announced last month. ADAC will continue to support its installed base of LIS customers, but has no plans to enter the market for new LIS products.

ADAC gained access to LabStat through its 1995 acquisition of Community Health Computing, which had filed for bankruptcy five months earlier. ADAC pursued the acquisition as part of its strategy to expand its RIS business.

The costs of completing development of LabStat were a drain on the company, and eventually ADAC decided to pull the plug. ADAC's RIS business continues to perform well, however, and the company plans to keep its ADAC HealthCare Information Systems business in Houston.

Recent Videos
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.